Ọbara na-ebute shuga dị n'ọbara

Ọbara shuga dị n'ọbara bụ obere glucose dị n'ọbara nke na-esite n'ị medicineụ ọgwụ.

Ọbara shuga dị n'ọbara (hypoglycemia) bụ nke ndị mmadụ na-arịa ọrịa shuga na-a insụ insulin ma ọ bụ ọgwụ ndị ọzọ iji chịkwaa ọrịa shuga ha.

Ndị ọzọ karịa ụfọdụ ọgwụ, ihe ndị a nwekwara ike ime ka ogo shuga (glucose) belata:

• Ụ mmanya na-aba n'anya
• Na-eme ihe karịa na mbụ
• Int overụbiga ọgwụ ókè n'amaghị ama ma ọ bụ n'amaghị ama
• Na-efu nri

Ọbụna mgbe ejiri nlezianya jikwaa ọrịa shuga, ọgwụ ndị e ji agwọ shuga nwere ike ibute shuga dị n'ọbara nke ọgwụ na-akpata. Ọnọdụ ahụ nwekwara ike ịpụta mgbe onye na-enweghị ọrịa shuga na-a aụ ọgwụ eji agwọ ọrịa shuga. N'ọnọdụ ndị a na-adịghị ahụkebe, ọgwụ ndị na-abụghị ọrịa shuga nwere ike ibute shuga dị n'ọbara.

Ọgwụ nke nwere ike ibute shuga dị ala n'ọbara gụnyere:

• Beta-blockers (dị ka atenolol, ma ọ bụ propanolol overdose)
• Cibenzoline na quinidine (ọgwụ arrhythmia obi)
• Indomethacin (ihe mgbu)
• Insulin
• Metformin mgbe ejiri ya na sulfonylureas
• Ndị na-emechi SGLT2 (dịka dapagliflozin na empagliflozin) nwere ma ọ bụ na-enweghị sulfonylureas
• Sulfonylureas (dika glipizide, glimepiride, glyburide)
• Thiazolidinediones (dị ka pioglitazone na rosiglitazone) mgbe ejiri ya na sulfonylureas
• Ọgwụ na-alụso ọrịa ọgụ (dị ka gatifloxacin, pentamadine, quinine, trimethoprim-sulfamethoxazole)

Hypoglycemia - ọgwụ na-akpata; Ọbara ọbara dị ala - ọgwụ na-akpata

• Ntọhapụ nri na insulin

ANA EGO Ebumnuche Glycemic na ọrịa shuga: ịzụ ahịa n'etiti njikwa glycemic na hypoglycemia iatrogenic. Ọrịa shuga. 2014; 63 (7): 2188-2195. PMID: 24962915 www.ncbi.nlm.nih.gov/pubmed/24962915.

Gale EAM, Anderson JV. Ọrịa shuga. Na: Kumar P, Clark M, ụmụ nwoke. Kumar na Clarke's Clinical Medicine. Agba nke 9. Philadelphia, PA: Elsevier; 2017: isi 27.